Frequently Asked Questions

Our investment process typically takes 4-8 weeks from initial submission to final decision. This includes initial review (48 hours), partner meetings (1 week), due diligence (2-4 weeks), and investment committee decision (1-2 weeks). We prioritize transparency and will keep you informed throughout the process.

We require a pitch deck (10-15 slides), executive summary, financial model, and basic company information. Your pitch deck should cover problem/solution, market opportunity, business model, traction, team, and funding requirements. We also appreciate demo videos or product walkthroughs when available.

Yes, we believe in providing constructive feedback to all entrepreneurs who reach our partner meeting stage. While we can't provide detailed feedback on every submission due to volume, we do offer insights on companies that align with our investment thesis but may not be the right fit at the current time.

We focus on early-stage companies from Seed to Series B. This typically includes companies with initial traction, proven product-market fit, and clear growth trajectory. We occasionally consider pre-seed companies with exceptional teams and breakthrough technology, as well as later-stage companies in our core focus areas.

Our initial investments range from $500K to $15M, depending on the stage and funding requirements. We prefer to lead or co-lead rounds and typically reserve capital for follow-on investments in our portfolio companies. We can also participate in larger rounds alongside other institutional investors.

While we primarily focus on Enterprise SaaS, HealthTech, AI/ML, and FinTech, we occasionally consider exceptional opportunities in adjacent technology sectors. The key factors are strong founding teams, large market opportunities, and alignment with our expertise and network capabilities.

We provide comprehensive support including strategic guidance, business development, talent recruitment, customer introductions, follow-on funding assistance, and access to our extensive network of advisors, partners, and industry experts. We also offer operational support in areas like sales, marketing, and scaling operations.

We believe in supporting without micromanaging. Typically, we take board seats or board observer roles and meet monthly or quarterly depending on the company's needs. We're available for strategic decisions and challenges but respect the autonomy of founding teams to run their businesses.

Absolutely. We actively support our portfolio companies in raising follow-on funding by making introductions to our network of co-investors, helping prepare materials, and often participating in subsequent rounds ourselves. Our goal is to support companies through multiple growth stages.

Our equity stake varies based on the investment stage, amount, and company valuation, typically ranging from 10-25%. We focus on fair valuations that reflect the company's current stage and growth potential while ensuring meaningful ownership that aligns our interests with the founding team.

For lead investments, we typically take a board seat to provide strategic guidance and governance oversight. For smaller investments or co-investments, we may take board observer rights. Our approach is collaborative, focusing on adding value rather than control.

We use market-standard terms including preferred stock with standard liquidation preferences, anti-dilution provisions, and pro-rata rights for follow-on investments. We believe in founder-friendly terms that align interests while protecting our investment. Specific terms are negotiated based on each opportunity.